Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360
android app
/
iOS App/ web portal.
{
"products": [
{
"_id": "6ad74702e53c888beeab308d",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Empagliozin 10 mg, Sitagliptin 100 mg and Metformin hydrochloride 1000 mg ER Tablets",
"description": "GLIEMPAFLOZIN 3D 10 is a triple-combination antidiabetic tablet containing Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride Extended Release (ER) 1000 mg. This combination is intended for the management of type 2 diabetes mellitus in appropriately selected patients under the supervision of a qualified healthcare professional.\n\nThe three active ingredients work through different mechanisms to help regulate blood glucose levels. Empagliflozin helps the kidneys eliminate glucose through urine, Sitagliptin supports glucose-dependent insulin regulation, and Metformin helps reduce glucose production in the liver while improving insulin sensitivity.\n\nBy combining these ingredients in one tablet, GLIEMPAFLOZIN 3D 10 provides a multi-mechanism approach to blood glucose management. Its suitability depends on the patient's clinical condition, kidney function, existing treatment, and the approved prescribing information.\n\nComposition of GLIEMPAFLOZIN 3D 10\nEach tablet contains the following stated active ingredients:\n\nEmpagliflozin 10 mg: A sodium-glucose cotransporter 2 (SGLT2) inhibitor that reduces glucose reabsorption by the kidneys and increases glucose excretion through urine.\nSitagliptin 100 mg: A dipeptidyl peptidase-4 (DPP-4) inhibitor that helps regulate insulin and glucagon responses according to blood glucose levels.\nMetformin Hydrochloride ER 1000 mg: An extended-release biguanide that primarily reduces glucose production in the liver and improves the body's response to insulin.\nThe exact formulation, excipients, approved indications, and administration instructions should be confirmed from the product packaging and official prescribing information.\n\nKey Features of GLIEMPAFLOZIN 3D 10 Tablets\nGLIEMPAFLOZIN 3D 10 combines three established antidiabetic medicines with complementary mechanisms of action.\n\nTriple-combination formulation: Contains Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER.\nMultiple glucose-control pathways: Targets different processes involved in blood glucose regulation.\nExtended-release metformin: Provides a formulation designed to release Metformin gradually over time.\nOral tablet dosage form: Allows administration according to the prescribed regimen.\nIndividualized diabetes management: May be considered when a healthcare professional determines that all three ingredients are appropriate.\nThe combination is not suitable for every person with diabetes. Treatment decisions should be based on individual medical needs and the approved product information.\n\nUses of GLIEMPAFLOZIN 3D 10\nGLIEMPAFLOZIN 3D 10 is intended for the management of type 2 diabetes mellitus, subject to its approved indications and the prescribing healthcare professional's assessment.\n\nType 2 diabetes is a chronic metabolic condition characterized by impaired insulin action and, in many patients, insufficient insulin production. Persistently elevated blood glucose can increase the risk of complications affecting the eyes, kidneys, nerves, heart, and blood vessels.\n\nThe three active ingredients in GLIEMPAFLOZIN 3D 10 address different aspects of glucose regulation. A healthcare professional may consider this combination when multiple medicines are required to achieve an individual's treatment goals and when the combination is clinically appropriate.\n\nThe medicine should be used as part of a comprehensive diabetes-management plan that may include balanced nutrition, regular physical activity, blood glucose monitoring, and routine medical assessments. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.\n\nHow Does GLIEMPAFLOZIN 3D 10 Work?\n1. Empagliflozin 10 mg\nEmpagliflozin belongs to the SGLT2 inhibitor class. It blocks a protein responsible for reabsorbing glucose filtered by the kidneys. This allows more glucose to be eliminated through urine, helping reduce blood glucose levels.\n\nEmpagliflozin has also demonstrated cardiovascular and kidney benefits in certain eligible patient populations. Whether these benefits apply to an individual depends on their clinical condition and the applicable prescribing information.\n\n2. Sitagliptin 100 mg\nSitagliptin inhibits the DPP-4 enzyme, which breaks down incretin hormones. By increasing incretin activity, Sitagliptin supports insulin release when blood glucose is elevated and helps regulate glucagon secretion. These actions contribute to blood glucose control.\n\n3. Metformin Hydrochloride ER 1000 mg\nMetformin primarily reduces glucose production in the liver and improves insulin sensitivity. The extended-release formulation is designed to release the medicine gradually over time.\n\nTogether, these ingredients target several pathways involved in type 2 diabetes. Their combined effectiveness and safety depend on appropriate prescribing, correct administration, and regular monitoring.\n\nPotential Benefits of GLIEMPAFLOZIN 3D 10\nWhen prescribed for an appropriate patient, GLIEMPAFLOZIN 3D 10 may offer the following treatment advantages:\n\nMultiple mechanisms of action: Combines three medicines that influence different aspects of glucose regulation.\nBlood glucose management: Helps improve glycemic control in eligible adults with type 2 diabetes.\nCombination therapy: May simplify a treatment regimen compared with taking the same ingredients as separate tablets.\nExtended-release component: Includes Metformin Hydrochloride ER for gradual drug release.\nPersonalized treatment options: May be considered when a healthcare professional determines that triple therapy is appropriate.\nIndividual outcomes vary, and the medicine does not replace a suitable diet, physical activity, or routine diabetes care.\n\nDirections for Use\nTake GLIEMPAFLOZIN 3D 10 only as prescribed by your healthcare professional.\n\nFollow the prescribed dose and administration schedule.\nTake the tablet with food if directed by the product labeling or your prescriber.\nSwallow the extended-release tablet whole unless the specific product instructions state otherwise. Do not crush, chew, or split it without professional guidance.\nDo not change the dose or stop treatment without consulting your prescriber.\nAttend recommended appointments for kidney-function assessment and blood glucose monitoring.\nIf you miss a dose, follow the official patient information or ask your healthcare professional or pharmacist what to do. Do not take an extra dose to compensate for a missed dose unless specifically instructed.\n\nPrecautions and Safety Information\nGLIEMPAFLOZIN 3D 10 is a prescription medicine and may not be suitable for everyone.\n\nKidney function: Kidney function should be assessed before and during treatment as appropriate. Metformin and Empagliflozin have important kidney-related prescribing considerations.\n\nDehydration: Empagliflozin increases glucose excretion through urine and may increase urination. Patients at risk of dehydration or low blood pressure should discuss appropriate precautions with their healthcare professional.\n\nGenital and urinary infections: Empagliflozin may increase the risk of genital fungal infections and can be associated with urinary tract infections.\n\nLactic acidosis: Metformin can rarely cause a serious condition called lactic acidosis. Risk may increase with significant kidney impairment, severe dehydration, certain acute illnesses, or excessive alcohol intake.\n\nPancreatitis: Pancreatitis has been reported in patients taking Sitagliptin. Severe, persistent abdominal pain requires prompt medical assessment.\n\nHypoglycemia: Low blood glucose may occur, particularly when the combination is used with insulin or insulin secretagogues such as sulfonylureas.\n\nInform your healthcare professional about existing medical conditions, all medicines you take, pregnancy or breastfeeding, planned surgery, prolonged fasting, and upcoming procedures involving iodinated contrast. Follow professional instructions about temporary medicine interruption during acute illness or other high-risk situations.\n\nSeek urgent medical care for severe abdominal pain, difficulty breathing, persistent vomiting, severe dehydration, or other serious symptoms.\n\nWhy Choose GLIEMPAFLOZIN 3D 10?\nGLIEMPAFLOZIN 3D 10 brings together Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg in a triple-combination tablet intended for selected patients with type 2 diabetes.\n\nFor pharmaceutical websites, pharmacies, distributors, and healthcare professionals, clear information about composition, mechanism of action, potential uses, and precautions supports responsible product awareness.\n\nAlways refer to the approved product label for the exact composition, indications, dosage, contraindications, storage requirements, and instructions for use.\n\nConclusion\nGLIEMPAFLOZIN 3D 10 Tablets combine Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg to target multiple pathways involved in blood glucose regulation. The combination may be appropriate for selected adults with type 2 diabetes under medical supervision.\n\nFor complete information about dosage, contraindications, warnings, storage, and approved indications, consult the official product packaging and prescribing information. Use this medicine only under the direction of a qualified healthcare professional.\n\nFrequently Asked Questions (FAQs)\n1. What is GLIEMPAFLOZIN 3D 10?\n\nGLIEMPAFLOZIN 3D 10 is a combination tablet containing Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg.\n\n2. What is GLIEMPAFLOZIN 3D 10 used for?\n\nIt is intended for the management of type 2 diabetes mellitus in patients for whom this combination is considered appropriate by a healthcare professional.\n\n3. How does GLIEMPAFLOZIN 3D 10 work?\n\nEmpagliflozin increases urinary glucose excretion, Sitagliptin supports glucose-dependent insulin regulation, and Metformin reduces glucose production in the liver and improves insulin sensitivity.\n\n4. Can GLIEMPAFLOZIN 3D 10 replace diet and exercise?\n\nNo. Medication should be combined with an individualized diet, physical activity, and monitoring plan recommended by a healthcare professional.\n\n5. Is GLIEMPAFLOZIN 3D 10 suitable for everyone with diabetes?\n\nNo. Suitability depends on the type of diabetes, kidney function, other medical conditions, concurrent medicines, and approved prescribing information.\n\n",
"price": 210.0,
"discountamount": 147.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2505,
"imageuri": "https://productimages.withfloats.com/actual/6ad7470422551901df6e5493.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6ad7470422551901df6e5493.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-10-20T10:48:34.116Z",
"updatedon": "2026-10-20T10:48:34.116Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/empagliozin-10-mg-sitagliptin-100-mg-and-metformin-hydrochloride-1000-mg-er-tablets/2505",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIEMPAFLOZIN 3D 10",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6ad7442bf24c5a4bbccf4b10",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Empagliflozin,Sitagliptin And Metformin Hydrochloride (ER) Tablets",
"description": "GLIEMPAFLOZIN 3D 25 is a combination pharmaceutical product containing Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride Extended Release (ER) 1000 mg. This triple-combination formulation is intended for the management of type 2 diabetes mellitus in appropriate patients, as determined by a qualified healthcare professional.\n\nThe three active ingredients work through different mechanisms to help control blood glucose levels. Empagliflozin belongs to the sodium-glucose cotransporter 2 (SGLT2) inhibitor class, Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, and Metformin is a biguanide antidiabetic medicine. Together, these ingredients target different pathways involved in glucose regulation.\n\nGLIEMPAFLOZIN 3D 25 provides a combination of three established antidiabetic agents in a single tablet. Its suitability depends on the patient's blood glucose levels, kidney function, current diabetes treatment, medical history, and the approved prescribing information.\n\nComposition of GLIEMPAFLOZIN 3D 25\nEach tablet contains the following stated active ingredients:\n\nEmpagliflozin 25 mg: An SGLT2 inhibitor that helps the kidneys remove glucose from the bloodstream through urine.\nSitagliptin 100 mg: A DPP-4 inhibitor that increases the activity of incretin hormones involved in glucose-dependent insulin release and glucagon regulation.\nMetformin Hydrochloride ER 1000 mg: An extended-release biguanide that primarily reduces glucose production in the liver and improves the body's response to insulin.\nThe exact formulation, excipients, administration instructions, and approved indications should be verified against the product packaging and official prescribing information.\n\nKey Features of GLIEMPAFLOZIN 3D 25\nGLIEMPAFLOZIN 3D 25 combines three antidiabetic ingredients with complementary mechanisms of action.\n\nTriple-combination formulation: Contains Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER.\nMultiple glucose-control pathways: The ingredients act through different mechanisms involved in blood glucose regulation.\nExtended-release metformin: The ER formulation is designed to release metformin over an extended period.\nOral tablet dosage form: Provides oral administration according to the prescribed regimen.\nIndividualized diabetes management: May be considered by a healthcare professional when combination therapy is appropriate.\nThe benefits of this combination depend on the patient's clinical needs and the suitability of all three ingredients.\n\nUses of GLIEMPAFLOZIN 3D 25 Tablets\nGLIEMPAFLOZIN 3D 25 is intended for the management of type 2 diabetes mellitus, subject to the product's approved indications and the prescribing healthcare professional's judgment.\n\nType 2 diabetes is a chronic metabolic condition in which the body does not use insulin effectively or does not produce enough insulin to maintain healthy blood glucose levels. Long-term elevated blood glucose can increase the risk of complications affecting the eyes, kidneys, nerves, heart, and blood vessels.\n\nThe three medicines in GLIEMPAFLOZIN 3D 25 target different aspects of glucose regulation. A healthcare professional may consider a combination regimen when an individual's treatment goals are not adequately achieved with a simpler regimen or when the combination is otherwise clinically appropriate.\n\nThe medicine should be used alongside an individualized diabetes-management plan that may include a balanced diet, physical activity, glucose monitoring, and regular medical follow-up. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.\n\nHow Does GLIEMPAFLOZIN 3D 25 Work?\nThe three active ingredients contribute to blood glucose management through distinct mechanisms.\n\n1. Empagliflozin 25 mg\nEmpagliflozin inhibits SGLT2, a protein responsible for reabsorbing much of the glucose filtered by the kidneys. By reducing glucose reabsorption, it increases glucose excretion through urine and helps lower blood glucose levels.\n\nEmpagliflozin has also demonstrated cardiovascular and kidney benefits in certain eligible patient populations. These benefits depend on the patient's condition and the applicable prescribing information and should not be assumed to apply identically to every patient.\n\n2. Sitagliptin 100 mg\nSitagliptin inhibits the DPP-4 enzyme, which breaks down incretin hormones. Increasing incretin activity helps stimulate insulin release when blood glucose is elevated and reduces glucagon secretion when appropriate. This helps regulate glucose levels, particularly after meals.\n\n3. Metformin Hydrochloride ER 1000 mg\nMetformin primarily decreases glucose production in the liver and improves insulin sensitivity. The extended-release formulation is designed to release the medicine gradually over time.\n\nBy combining these mechanisms, GLIEMPAFLOZIN 3D 25 targets several pathways involved in type 2 diabetes. Its overall effectiveness and safety depend on appropriate patient selection, dosing, and ongoing monitoring.\n\nPotential Benefits of GLIEMPAFLOZIN 3D 25\nWhen prescribed for an appropriate patient, this combination may offer the following treatment advantages:\n\nMultiple mechanisms of action: Addresses glucose regulation through three different pharmacological pathways.\nBlood glucose management: Helps improve glycemic control in eligible adults with type 2 diabetes.\nOral combination therapy: Combines three medicines in one tablet, which may simplify a prescribed regimen compared with taking each ingredient separately.\nExtended-release component: Includes Metformin Hydrochloride ER for gradual drug release.\nIndividualized treatment options: May be considered when a healthcare professional determines that all three ingredients are appropriate.\nThese potential advantages do not guarantee a particular result. Treatment effectiveness depends on adherence, diet, physical activity, individual health status, and medical supervision.\n\nDirections for Use\nGLIEMPAFLOZIN 3D 25 should be taken only as prescribed by a qualified healthcare professional.\n\nFollow the prescribed dose and administration schedule.\nTake the tablet with food if directed by the product labeling or prescriber.\nSwallow the extended-release tablet whole unless the specific product instructions state otherwise. Do not crush, chew, or split it without professional guidance.\nDo not change the dose or discontinue treatment without consulting your prescriber.\nAttend recommended appointments for blood glucose monitoring and kidney-function assessment.\nIf a dose is missed, follow the official patient information or ask your healthcare professional or pharmacist for advice. Do not take an extra dose to compensate for a missed dose unless specifically instructed.\n\nPrecautions and Safety Information\nGLIEMPAFLOZIN 3D 25 is a prescription medicine and is not suitable for everyone.\n\nKidney function: Kidney function should be assessed before and during treatment as appropriate. Metformin and Empagliflozin have important renal considerations, and the combination may be unsuitable at certain levels of kidney impairment.\n\nDehydration: Empagliflozin increases glucose excretion through urine and may increase urination. Patients should discuss dehydration risk, low blood pressure, and fluid intake with their healthcare professional.\n\nGenital and urinary infections: Empagliflozin can increase the risk of genital fungal infections and may be associated with urinary tract infections.\n\nLactic acidosis: Metformin can rarely cause a serious condition called lactic acidosis. Risk may increase with significant kidney impairment, severe dehydration, certain acute illnesses, excessive alcohol intake, or other predisposing conditions.\n\nPancreatitis: Pancreatitis has been reported in patients taking Sitagliptin. Severe, persistent abdominal pain requires prompt medical assessment.\n\nLow blood glucose: The risk of hypoglycemia may increase when this combination is used with insulin or insulin secretagogues, such as sulfonylureas.\n\nInform your healthcare professional about existing medical conditions, all medicines you take, pregnancy or breastfeeding, planned surgery, prolonged fasting, or an upcoming medical procedure involving iodinated contrast. Follow professional instructions about temporary medicine interruption during acute illness or other high-risk situations.\n\nSeek urgent medical care for severe abdominal pain, difficulty breathing, unusual weakness, persistent vomiting, severe dehydration, or other serious symptoms.\n\nWhy Choose GLIEMPAFLOZIN 3D 25?\nGLIEMPAFLOZIN 3D 25 brings together Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER in a triple-combination tablet designed for the management of type 2 diabetes in appropriately selected patients.\n\nFor pharmaceutical product catalogues, distributors, pharmacies, and healthcare professionals, accurate information about the composition, mechanism of action, approved indications, and safety profile supports responsible product awareness.\n\nTreatment decisions should always be based on the patient's medical assessment and the approved product information.\n\nConclusion\nGLIEMPAFLOZIN 3D 25 Tablets combine Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg to target multiple pathways involved in blood glucose regulation. This combination may be appropriate for selected adults with type 2 diabetes under medical supervision.\n\nFor complete information about dosage, contraindications, warnings, storage, and approved indications, consult the official product packaging and prescribing information. Use this medicine only under the direction of a qualified healthcare professional.\n\nFrequently Asked Questions (FAQs)\n1. What is GLIEMPAFLOZIN 3D 25?\n\nGLIEMPAFLOZIN 3D 25 is a combination tablet containing Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg.\n\n2. What is GLIEMPAFLOZIN 3D 25 used for?\n\nIt is intended for the management of type 2 diabetes mellitus in patients for whom the combination is considered appropriate by a healthcare professional.\n\n3. How does GLIEMPAFLOZIN 3D 25 work?\n\nEmpagliflozin increases urinary glucose excretion, Sitagliptin supports glucose-dependent insulin regulation, and Metformin reduces glucose production in the liver and improves insulin sensitivity.\n\n4. Can GLIEMPAFLOZIN 3D 25 replace diet and exercise?\n\nNo. Medication should be combined with an individualized diet, physical activity, and monitoring plan as recommended by a healthcare professional.\n\n5. Is GLIEMPAFLOZIN 3D 25 suitable for everyone with diabetes?\n\nNo. Its suitability depends on the type of diabetes, kidney function, other medical conditions, concurrent medicines, and the approved prescribing information.",
"price": 230.0,
"discountamount": 69.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2504,
"imageuri": "https://productimages.withfloats.com/actual/6ad7442d6e565c5fe6e5b7cb.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6ad7442d6e565c5fe6e5b7cb.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-10-20T10:36:27.325Z",
"updatedon": "2026-10-20T10:36:27.325Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//empagliflozin-sitagliptin-and-metformin-hydrochloride-er-tablets/2504",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIEMPAFLOZIN 3D 25",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a5092283075a19d4f2db6bd",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Cyclosporine Eye Drops 0.05% w/v",
"description": "Cyclosporine eye drops 0.05% are a prescription ophthalmic emulsion used to treat chronic dry eye disease (keratoconjunctivitis sicca) caused by ocular surface inflammation. Unlike lubricating tear substitutes that only manage symptoms, cyclosporine works as a calcineurin-inhibitor immunomodulator that calms the underlying inflammation suppressing your eyes' natural tear production. It is not a steroid. The standard dose is one drop in each affected eye, twice daily, about 12 hours apart, and visible improvement in tear production typically takes 6–12 weeks, with full benefit sometimes taking up to 3–6 months of consistent use. Common side effects include temporary burning, stinging, redness, and watery eyes at the time of instillation. It is a Schedule H prescription-only medicine in India and should be used only under a qualified ophthalmologist's guidance.\n\nWhat Is Cyclosporine Eye Drops 0.05%?\nCyclosporine eye drops 0.05% (ophthalmic emulsion) is a prescription formulation designed to manage chronic dry eye disease, a condition in which the eyes fail to produce enough tears or produce tears of poor quality, often because of an underlying inflammatory process on the ocular surface and in the lacrimal (tear-producing) gland.\nThis formulation is commonly prescribed for patients whose dry eye is presumed to be due to ocular inflammation — for example, those with moderate to severe dry eye, keratoconjunctivitis sicca, or dry eye associated with conditions like Sjögren's syndrome, that has not responded adequately to artificial tears alone.\nCyclosporine belongs to a class of drugs called calcineurin inhibitors. It differs fundamentally from corticosteroid eye drops, which suppress inflammation broadly and carry risks like raised intraocular pressure and cataract formation with long-term use. Cyclosporine instead selectively dampens the T-cell-mediated inflammatory response that is thought to suppress tear gland function, allowing the eye's own tear-producing mechanism to gradually recover.\n\nHow Do Cyclosporine Eye Drops Work? (Mechanism of Action)\n\nInflammation on the ocular surface – In chronic dry eye, T-lymphocytes infiltrate the conjunctiva and lacrimal gland, triggering a self-perpetuating inflammatory cycle.\nCalcineurin inhibition – Cyclosporine binds to a cellular protein (cyclophilin) and blocks calcineurin, an enzyme required to activate T-cells.\nReduced T-cell activation – With calcineurin blocked, T-cells cannot produce the inflammatory signals (such as interleukin-2) that damage the lacrimal gland and conjunctival tissue.\nRestoration of tear production – As local inflammation subsides over weeks to months, the lacrimal gland's ability to produce natural tears gradually improves.\nImproved tear film stability – With reduced inflammation and increased natural tear volume, patients typically notice less dryness, grittiness, and ocular surface damage over time.\n\nThis is why cyclosporine drops are described as disease-modifying for dry eye rather than purely symptomatic — they address a root inflammatory cause instead of simply lubricating the eye.\n\nClinical Indications\nIndicationDetailsChronic dry eye disease (keratoconjunctivitis sicca)Primary approved use; especially where tear production is suppressed due to ocular inflammationModerate to severe dry eye not controlled by artificial tearsSecond-line option when lubricants alone are insufficientDry eye associated with autoimmune conditionsE.g., Sjögren's syndrome-related dry eye, under specialist supervisionPost-refractive surgery dry eye (select cases)Sometimes used off-label under ophthalmologist guidance\n\nDosage & Administration\nParameterRecommendationStandard doseOne drop in each affected eye, twice dailyDosing intervalApproximately 12 hours apartContact lens useRemove lenses before instillation; wait at least 15 minutes before reinsertingOnset of noticeable effectUsually 6–12 weeksFull therapeutic benefitMay take up to 3–6 months of continuous useMissed doseContinue with next scheduled dose; do not double upDiscontinuationOnly under medical advice — symptoms may return if stopped prematurely\nNote: Cyclosporine eye drops are for long-term, continuous use as directed by your ophthalmologist. Improvement is gradual, not immediate, and consistent daily use is essential for benefit.\n\nKey Benefits\n\nTargets the underlying inflammatory cause of chronic dry eye rather than only masking symptoms\nCan increase natural tear production over sustained use\nGenerally well tolerated for long-term use, since it is not a steroid and does not carry steroid-related risks like elevated eye pressure or cataract with routine use\nMay reduce dependence on frequent artificial tear instillation over time\nSuitable for long-term maintenance therapy in chronic, relapsing dry eye disease\nCan improve comfort during visually demanding tasks (screen use, reading, driving) affected by chronic dryness\n\n\nPrecautions\n\nUse strictly as prescribed by an ophthalmologist; do not self-medicate\nNot intended for immediate relief of dry eye symptoms — artificial tears may be used concurrently for interim comfort as advised by your doctor\nShould not be used in the presence of an active ocular infection unless specifically directed by a physician\nInform your doctor if you are pregnant, breastfeeding, or have any known hypersensitivity to cyclosporine or emulsion components\nAvoid touching the dropper tip to the eye or any surface to prevent contamination\nIf wearing contact lenses, remove before application and reinsert only after 15 minutes\nDo not use expired or previously opened single-use vials, if applicable to your product format\nRegular ophthalmic follow-up is recommended to monitor treatment response\n\n\nSide Effects\nCommon (Usually Mild and Temporary)\n\nBurning or stinging sensation upon instillation\nEye redness\nWatery eyes (excessive tearing)\nEye discomfort or a feeling of something in the eye\nTemporary blurred vision immediately after application\n\nLess Common / Serious (Consult Your Doctor Promptly)\n\nPersistent or worsening eye pain\nSigns of eye infection (discharge, significant redness, swelling)\nVisual disturbance that does not resolve\nSigns of an allergic reaction (eyelid swelling, itching, rash)\n\nIf any serious or persistent symptom occurs, discontinue use and consult your ophthalmologist immediately.\n\nComparison: Cyclosporine Eye Drops vs. Other Dry Eye Treatments\nTreatmentMechanismOnset of ActionLong-Term Use ProfileCyclosporine 0.05% dropsCalcineurin inhibitor; reduces inflammation, restores natural tear productionWeeks to monthsGenerally suitable for continuous long-term useArtificial tears / lubricantsSymptomatic lubrication onlyImmediate, short-livedSafe but does not address inflammation; frequent reapplication neededCorticosteroid eye dropsBroad anti-inflammatory actionFast (days)Not recommended for long-term use due to risk of raised IOP, cataractLifitegrast ophthalmic solutionLFA-1 antagonist; blocks a different inflammatory pathwayWeeksAlternative option, mechanism differs from cyclosporine\n\nKey Statistics (Placeholder — Pending Clinical Reviewer Verification)\nMetricValueReported patients showing improved tear production at 6 months[Placeholder – insert verified clinical trial statistic]Prevalence of chronic dry eye disease in adults[Placeholder – insert epidemiological reference]Average time to symptomatic improvement[Placeholder – insert verified reference range]\nAll statistics above are placeholders and must be verified and populated by a qualified clinical reviewer prior to publication.\n\nExpert Insight\n\n[Placeholder — Expert quote pending. To be added only after review and approval by a licensed ophthalmologist/medical reviewer associated with Steris Healthcare. Do not fabricate or publish without sign-off.]\n\n\nPrice of Cyclosporine Eye Drops 0.05%\nThe price of cyclosporine eye drops 0.05% varies depending on pack size, brand, and region. For current pricing, availability, and prescription verification, please consult your ophthalmologist or authorized pharmacy.\nPrescription only – consult your doctor.\n\nConclusion\nCyclosporine eye drops 0.05% represent a meaningful shift in how chronic dry eye disease is managed — moving beyond temporary lubrication to address the underlying inflammatory process that suppresses natural tear production. For patients with moderate to severe dry eye that hasn't responded well to artificial tears alone, this calcineurin-inhibitor therapy offers a disease-modifying option that, with consistent long-term use, can meaningfully improve ocular comfort and tear film health. Because benefits build gradually over weeks to months, patience and adherence to the prescribed twice-daily regimen are essential. As with any prescription ophthalmic therapy, cyclosporine eye drops should only be used under the guidance of a qualified ophthalmologist, who can confirm suitability, monitor progress, and adjust care as needed.\n\nFrequently Asked Questions\n\n1. What are cyclosporine 0.05% eye drops used for?\nCyclosporine 0.05% eye drops are used to treat chronic dry eye disease caused by ocular surface inflammation. They help increase natural tear production in patients whose tear glands are suppressed due to inflammation, particularly when artificial tears alone aren't enough.\n\n2. How long can I use cyclosporine eye drops?\nCyclosporine eye drops are typically used long-term, as chronic dry eye is an ongoing condition. Many patients continue therapy for months to years under regular ophthalmologist supervision, since symptoms can return if the medication is stopped.\n\n3. Is Cyclomune a steroid?\nNo. Cyclomune (a brand of cyclosporine ophthalmic emulsion) is not a steroid. It is a calcineurin-inhibitor immunomodulator that works differently from steroid eye drops and does not carry the same risk of raised eye pressure or cataract associated with long-term steroid use.\n4. How quickly do cyclosporine eye drops start working?\nMost patients begin noticing improvement in tear production and dry eye symptoms within 6 to 12 weeks, though full benefit may take up to 3 to 6 months of consistent, twice-daily use.\n\n5. Can cyclosporine damage eyes?\nWhen used exactly as prescribed, cyclosporine eye drops are generally considered safe for long-term use. Temporary burning, stinging, or watering can occur at the time of instillation, but serious eye damage is uncommon. Any persistent pain, vision changes, or signs of infection should be reported to your ophthalmologist promptly.\n\n6. How much are cyclosporine 0.05% eye drops?\nPricing varies by brand, pack size, and region. Since this is a prescription-only medicine, please check current pricing with your prescribing doctor or a licensed pharmacy.\n\n7. Is cyclosporine a steroid?\nNo. Cyclosporine is a calcineurin inhibitor, a category of immunomodulating medication that is pharmacologically distinct from corticosteroids (steroids), even though both can reduce inflammation.\n\n8. Can I wear contact lenses while using cyclosporine eye drops?\nContact lenses should be removed before applying the drops and can typically be reinserted after about 15 minutes, unless your ophthalmologist gives different instructions.\n9. What happens if I stop using cyclosporine eye drops suddenly?\nStopping suddenly may cause dry eye symptoms to gradually return, since the underlying inflammation is no longer being managed. Always consult your doctor before discontinuing treatment.\n\n10. Can cyclosporine eye drops be used with artificial tears?\nYes, in many cases artificial tears can be used alongside cyclosporine drops for additional comfort, especially during the initial weeks before cyclosporine's full effect develops. Confirm timing and spacing with your doctor.\n\n11. Who should not use cyclosporine eye drops?\nPatients with known hypersensitivity to cyclosporine or its components, active untreated eye infections, or specific contraindications identified by their doctor should not use this medication without medical clearance.\n\n12. Are cyclosporine eye drops safe during pregnancy?\nUse during pregnancy or breastfeeding should only occur under medical supervision. Inform your doctor if you are pregnant, planning pregnancy, or breastfeeding before starting treatment.\n\n13. What is the difference between cyclosporine eye drops and lubricating eye drops?\nLubricating (artificial tear) drops provide temporary symptomatic relief by adding moisture to the eye, while cyclosporine drops target the underlying inflammation responsible for reduced natural tear production, offering a longer-term, disease-modifying approach.\n\n14. Can children use cyclosporine eye drops?\nUse in children should only be under the direct guidance and prescription of a pediatric ophthalmologist, based on individual clinical assessment.\n\n15. Do cyclosporine eye drops cause blurred vision?\nTemporary blurred vision can occur immediately after instillation in some patients. This usually resolves quickly. If blurred vision persists, consult your doctor.\n\n16. Can cyclosporine eye drops be used with other eye medications?\nOther eye medications, including other prescription drops, should only be combined with cyclosporine under your ophthalmologist's guidance, with appropriate spacing between different drops.\n\n17. Why do cyclosporine eye drops take so long to work?\nBecause cyclosporine works by gradually reducing chronic inflammation in the lacrimal gland and ocular surface rather than providing instant lubrication, visible improvement in natural tear production takes weeks to months rather than being immediate.",
"price": 495.0,
"discountamount": 149.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2468,
"imageuri": "https://productimages.withfloats.com/actual/6a50922a464ced2a630398a1.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a50922a464ced2a630398a1.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-07-10T06:33:12.096Z",
"updatedon": "2026-07-10T06:33:12.096Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//cyclosporine-eye-drops-0-05-w-v/2468",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "CIPVISION CYCLOPURE 0.5 mg",
"category": "Opthalmology Range",
"tags": [
"Cyclosporine Eye Drops 0.05% w/v",
"cyclosporine eye drops",
"cyclosporine eye drops uses",
"cyclosporine eye drops ip 0.05 w/v",
"cyclosporine eye drops price",
"cyclosporine eye drops uses in hindi",
"cyclosporine eye drops side effects",
"cyclosporine eye drops 0.05",
"cyclosporine eye drops brand name",
"cyclosporine eye drops india"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6948f4ee5837f90c86a7e578",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Elagolix 200mg ",
"description": "Eligolux200 contains 200 mg of elagolix per tablet and is manufactured by Steris Healthcare Pvt Ltd in India as a prescription medication in packs of 3x10 tablets. Elagolix acts as a potent gonadotropin-releasing hormone (GnRH) receptor antagonist, binding competitively to GnRH receptors in the pituitary gland to rapidly reduce estrogen and progesterone levels without the initial flare-\nup seen in agonists. This mechanism starves endometrial-like tissue outside the uterus of hormonal stimulation, shrinking lesions and easing inflammation.\n\nAdminister Eligolux200 orally, swallowed whole with water, with or without food, typically starting within 7 days of menstrual onset. Standard dosing for severe cases involves 200mg twice daily for up to 6 months, or 150mg once daily extended to 24 months, adjusted by physicians based on tolerance and response. Store in a cool, dry place away from moisture and light, keeping out of children's reach.\n\nPrimary Uses\nEligolux200 targets moderate to severe endometriosis-associated pain, including dysmenorrhea (painful periods), nonmenstrual pelvic pain, and dyspareunia (painful intercourse). Endometriosis affects millions globally, causing tissue similar to the uterine lining to grow ectopically, leading to chronic inflammation, adhesions, and scarring. By dosing flexibly, Eligolux200 suits patients needing stronger suppression for intense symptoms, reducing reliance on opioids or surgery.\n\nClinical trials like Elaris EM-I and EM-II showed 75% dysmenorrhea reduction and 50-60% nonmenstrual pain relief at 6-12 months. It also curbs heavy menstrual bleeding in uterine fibroids, offering dual benefits for overlapping conditions. Physicians prescribe it when first-line NSAIDs or oral contraceptives fail, prioritizing non-invasive symptom control.\n\n\nKey Benefits\nEligolix in Eligolux200 delivers rapid pain relief, with significant improvements in daily pain scales within 3 months versus placebo. Women report 47% better composite pelvic pain scores, enhancing daily activities, work productivity, and intimacy. Quality-of-life metrics improve consistently over 24 weeks, including reduced fatigue and better emotional well-being.\n\n\nUnlike injectables, its oral form and dose-dependent estrogen suppression allow titration—lower doses minimize hypoestrogenic effects while higher 200mg dosing tackles severe pain. Studies confirm amenorrhea in 25% of users early on, slashing bleeding days by up to 50%. Long-term data up to 12 months with add-back therapy sustains efficacy, preserving bone health better than monotherapy. Patients regain control, avoiding invasive laparoscopies and reclaiming normalcy.\n\n\nBenefit\tEvidence from Trials'\tImpact on Patients\nDysmenorrhea Reduction:\t75% at 6 months \n\tFewer missed workdays\nNonmenstrual Pain Relief:\t50-60% improvement \n\tEnhanced mobility\nBleeding Control:\t14% bleeding days vs. 24% baseline \n\tImproved hygiene, anemia prevention\nQuality of Life\tSustained over 24 weeks \n\tBetter sleep, relationships\nPotential Side Effects\nCommon side effects of Eligolux200 mirror hypoestrogenic states: hot flashes, night sweats, headache, and nausea, each affecting about 10% of users. These often lessen as the body adjusts, with 69.5% overall adverse event rate over 24 weeks, mostly mild. Mood changes like irritability or depression occur less commonly, warranting mood monitoring.\n\n\nBone mineral density (BMD) loss poses a key concern—200mg twice daily causes -1.5% to -2.4% drops at lumbar spine and hip after 6 months, attenuated with calcium/vitamin D or add-back therapy. Rare serious risks include suicidal thoughts, liver enzyme elevations, or allergic reactions like anaphylaxis. Discontinuation due to events stays low at 4-12%. No deaths are linked directly to treatment in trials.\n\n\nSide Effect Category\tFrequency\tManagement\nVasomotor (Hot Flashes)\t9.9-10% \n\tLifestyle cooling, dose adjustment\nNeurologic (Headache)\t9.9% \n\tHydration, analgesics\nBone Loss\tUp to 2.4% at 6 months \n\tDEXA scans, supplements\nMood Changes\tLess common \n\tPsychiatric screening\nPrecautions and Contraindications\nAvoid Eligolux200 in pregnancy (risk of early loss), known osteoporosis, severe hepatic impairment, or with strong OATP1B1 inhibitors like cyclosporine or gemfibrozil. Women of childbearing age need effective non-hormonal contraception during and 28 days post-therapy, as it impairs recognition of pregnancy via amenorrhea. Not for pediatrics under 18 or geriatrics lacking data.\n\nScreen for depression history, liver function, and BMD before starting; monitor quarterly. Drug interactions abound with rifampin (reduces levels) or over 50 others like clarithromycin—inform physicians fully. Breastfeeding lacks safety data; weigh risks. Regular blood/urine tests track efficacy and safety.\n\n\nDosage Guidelines\nInitiate Eligolux200 at 150mg daily for milder cases, escalating to 200mg BID for dyspareunia or severe pain, max 6 months at higher dose. Miss a dose? Take promptly unless near the next; never double. Duration caps at 24 months total, with liver-adjusted lower dosing. Pair with add-back for extended use to curb BMD loss.\n\n\nPhysicians tailor based on response: 74-77% complete 6-month trials. Swallow intact; no crushing.\n\n\nClinical Evidence\nPhase III trials (Elaris EM-I/II) randomized 1689 women, proving both doses superior to placebo for co-primary endpoints of dysmenorrhea and nonmenstrual pain. Open-label extensions to 24 weeks maintained gains. A 12-month study with add-back showed persistent relief and <1% additional BMD loss versus placebo. Real-world use echoes this, positioning Eligolix as first oral GnRH antagonist approved for endometriosis.\n\n\nVersus relugolix, Eligolix offers comparable pelvic pain reduction with adjustable dosing. Indian brands like Eligolux200 align with global standards.\n\n\nConclusion\nEligolux200 transforms endometriosis management, delivering substantial pain relief and functional gains through precise hormonal control. Balancing robust benefits against manageable risks like BMD monitoring empowers women toward symptom-free lives. Consult healthcare providers for personalized integration into care plans.\n",
"price": 1000.0,
"discountamount": 300.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2251,
"imageuri": "https://productimages.withfloats.com/actual/694a2b9f403179ac7e958ef6.png",
"tileimageuri": "https://productimages.withfloats.com/tile/694a2b9f403179ac7e958ef6.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-12-22T07:36:14.316Z",
"updatedon": "2026-03-26T06:00:31.59Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//elagolix-200mg-/2251",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "ELIGOLUX 200",
"category": "GYANECOLOGYRANGE",
"tags": [
"Elagolix Tablets 200mg",
"Elagolix acts as a potent gonadotropin-releasing hormone.",
"nonmenstrual pelvic pain.",
"adhesions, and scarring",
"preserving bone health better than monotherapy.",
"avoiding invasive laparoscopies and reclaiming normalcy.",
"pituitary gland to rapidly reduce estrogen and progesterone.",
"tab elagolix 200mg",
"elagolix 200mg.",
"elagolix.",
"elagolix 200.",
"elagolix tablets",
"elagolix tablets uses.",
"elagolix 200 mg price.",
"elagolix mechanism of action.",
"elagolix 200 mg uses.",
"tab elagolixtab elagolix."
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6937c92e461b07808ef722e4",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "tab cyclosporine 100mg",
"description": "Cyclosporine, marketed under the brand name CYCLOPURE 100, is a potent immunosuppressant medication widely used in clinical settings to prevent organ transplant rejection and to manage various autoimmune disorders. Available as a 100mg oral capsule, CYCLOPURE 100 plays a critical role in modulating the immune system, helping patients maintain graft survival and control symptoms of immune-related diseases.\n\nProduct Description\nCYCLOPURE 100 contains cyclosporine, a cyclic polypeptide consisting of 11 amino acids, derived from the fungus Tolypocladium inflatum. It selectively inhibits the activity of T-lymphocytes, a subset of white blood cells that play a central role in immune response. By targeting these immune cells, cyclosporine helps prevent the body’s immune system from attacking transplanted organs, such as kidneys, liver, or heart, and reduces inflammation in autoimmune diseases.\n\nThe capsules are formulated for oral administration, with each capsule containing 100mg of cyclosporine. This dosage provides an effective balance between immunosuppression and safety for most adult patients, although dosing must be carefully tailored by healthcare providers based on patient response, therapeutic drug monitoring, and condition severity.\n\nUses of CYCLOPURE 100\nCYCLOPURE 100 is primarily indicated for the following medical purposes:\n\nPrevention of Organ Transplant Rejection: It is commonly prescribed to recipients of kidney, liver, heart, or other organ transplants to prevent acute and chronic rejection by suppressing immune responses that target the graft.\nAutoimmune Disease Management: Cyclosporine is effective in treating autoimmune disorders such as rheumatoid arthritis, psoriasis, and certain types of nephrotic syndrome. By reducing immune system overactivity, it helps alleviate symptoms such as joint inflammation, skin lesions, and kidney damage.\n\nSevere Atopic Dermatitis: In cases where conventional treatments are ineffective, cyclosporine may be used to control symptoms of severe eczema by modulating immune hyperreactivity.\n\nOther Off-Label Uses: Occasionally, cyclosporine is used for other immune-mediated conditions like uveitis, Crohn’s disease, and some forms of lupus nephritis depending on physician discretion.\n\nKey Benefits\nEffective Immunosuppression: CYCLOPURE 100 is known for its potent ability to suppress immune responses selectively, significantly reducing the risk of organ rejection after transplantation and improving graft survival rates.\n\nVersatility in Autoimmune Conditions: Beyond organ transplantation, cyclosporine’s immunomodulatory effects provide relief in autoimmune diseases by controlling inflammation and immune overactivity that cause tissue damage.\n\nImprovement in Quality of Life: By controlling disease symptoms such as joint pain, skin inflammation, or kidney impairment, CYCLOPURE 100 enables patients to experience improved physical comfort and daily functioning.\n\nOral Administration Convenience: The capsule form ensures ease of use and better patient compliance compared to injectable immunosuppressants, allowing therapy to be managed on an outpatient basis.\n\nTherapeutic Drug Monitoring: The availability of blood level monitoring helps customize dosage and maximize therapeutic effects while minimizing toxicity.\n\nSide Effects and Precautions\nWhile CYCLOPURE 100 is highly beneficial, it carries a risk of side effects due to its immunosuppressive nature and systemic effects. Common, less severe side effects include:\n\nGingival hyperplasia (gum overgrowth)\n\nTremors or mild neurological symptoms\n\nHypertension (high blood pressure)\n\nIncreased hair growth (hypertrichosis)\n\nGastrointestinal disturbances (nausea, diarrhea)\n\nMore serious adverse effects, which require immediate medical attention, can include:\n\nNephrotoxicity: Cyclosporine can affect kidney function; regular monitoring of kidney function tests is essential.\n\nIncreased Risk of Infections: Suppression of the immune system increases vulnerability to bacterial, viral, and fungal infections.\n\nHepatotoxicity: Liver function should be monitored, as cyclosporine may cause elevated liver enzymes or more severe liver damage.\n\nMalignancies: Long-term use has been associated with an increased risk of certain cancers, particularly lymphomas and skin cancers.\n\nElectrolyte Imbalances: Hypomagnesemia and hyperkalemia are possible and require monitoring.\n\nPatients must inform their healthcare providers about other medications they take, as cyclosporine has significant drug interactions that can affect its blood levels and toxicity risk, including with antibiotics, antifungals, anticonvulsants, and others.\n\nConclusion\nCYCLOPURE 100 (Cyclosporine 100mg) stands as a cornerstone immunosuppressant medication that plays a vital role in preventing organ rejection and managing autoimmune diseases. Its targeted immunosuppressive action effectively reduces disease burden, enhances graft survival, and improves patients’ quality of life. Although it entails risks of side effects, careful medical supervision, therapeutic drug monitoring, and adherence to prescribed dosing protocols effectively mitigate these concerns.\n\nFor patients undergoing organ transplantation or those with autoimmune conditions unresponsive to standard therapies, CYCLOPURE 100 provides a valuable therapeutic solution. Always consult a healthcare professional before starting or adjusting therapy with CYCLOPURE 100 to ensure the safest and most effective use tailored to individual clinical needs.",
"price": 1014.0,
"discountamount": 305.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2239,
"imageuri": "https://productimages.withfloats.com/actual/6937c930ed26b2c06ce34f7e.jpeg",
"tileimageuri": "https://productimages.withfloats.com/tile/6937c930ed26b2c06ce34f7e.jpeg",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-12-09T07:01:02.399Z",
"updatedon": "2026-03-30T07:51:22.499Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//tab-cyclosporine-100mg/2239",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "CYCLOPURE 100",
"category": "NEUROLOGY RANGE",
"tags": [
"Cyclosporine",
"fungus",
"white blood cells.",
"Prevention of Organ Transplant Rejection.",
"Autoimmune Disease Management.",
"tab cyclosporine 100mg.",
"cap cyclosporine 100mg.",
"cyclosporine 100mg price.",
"cyclosporine 100mg tablet.",
"cap cyclosporine 100mg uses in hindi.",
"cost of cyclosporine 100mg.",
"cyclosporine 100mg tablet price."
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "68d51d9a26579f4bc195771a",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "glimepiride voglibose metformin",
"description": "GLIMITERIS MV1 0.2 is an advanced fixed-dose combination (FDC) medication designed for adults with Type 2 Diabetes Mellitus (T2DM) who require more than lifestyle modifications or single/dual therapy to maintain optimal blood sugar levels. This innovative formulation brings together the power of three well-established antidiabetic agents—Glimepiride (1 mg), Voglibose (0.2 mg), and Metformin Hydrochloride SR (500 mg)—to provide comprehensive glycemic control.\n\nIt is particularly effective for patients struggling with postprandial hyperglycemia, fasting glucose regulation, and HbA1c reduction, making it a preferred choice in cases of poorly controlled diabetes.\n\n \n\nMechanism of Action\nThe therapeutic benefit of GLIMITERIS MV1 0.2 comes from the unique synergy of its three components, each targeting different aspects of glucose metabolism:\n\n1. Glimepiride (1 mg) – Sulfonylurea\nStimulates insulin secretion by activating pancreatic beta cells.\n\nProvides a long-lasting effect with comparatively lower hypoglycemia risk than older sulfonylureas.\n\nHelps reduce both fasting and postprandial glucose levels.\n\n2. Voglibose (0.2 mg) – Alpha-Glucosidase Inhibitor\nDelays the breakdown and absorption of carbohydrates in the intestine.\n\nMinimizes post-meal glucose spikes (PPBG).\n\nActs locally in the gut and has minimal systemic absorption, which reduces systemic side effects.\n\n3. Metformin Hydrochloride SR (500 mg) – Biguanide\nDecreases hepatic glucose production (gluconeogenesis).\n\nImproves peripheral insulin sensitivity, enhancing glucose uptake in muscles.\n\nDoes not cause hypoglycemia on its own.\n\nThe sustained-release (SR) formulation ensures extended control and reduces gastrointestinal side effects.\n\n \n\nIndications\nGLIMITERIS MV1 0.2 is indicated for:\n\nAdults with Type 2 Diabetes Mellitus.\n\nPatients inadequately controlled with monotherapy or dual therapy.\n\nManagement of fasting and postprandial hyperglycemia.\n\nLong-term HbA1c reduction as part of a comprehensive diabetes care plan.\n\n \n\nKey Benefits\n✅ Comprehensive Blood Sugar Control – Acts on fasting, post-meal, and long-term HbA1c levels.\n✅ Postprandial Spike Management – Voglibose effectively controls carbohydrate-induced sugar surges.\n✅ Reduced Pill Burden – Combines three medicines into a single tablet.\n✅ Lower Hypoglycemia Risk – Metformin and Voglibose balance out Glimepiride’s insulin-secreting effect.\n✅ Weight Management Support – Metformin may promote modest weight loss or prevent weight gain.\n✅ Improved Tolerability – SR formulation of Metformin enhances gastrointestinal comfort.\n\n \n\nDosage and Administration\nRecommended dose: One tablet once or twice daily with meals, or as directed by the physician.\n\nAdministration tips:\n\nTake with the first bite of a main meal to maximize Voglibose’s effect.\n\nSwallow whole with water; do not crush or chew the SR tablet.\n\nDose adjustments: Based on blood sugar monitoring, clinical response, and renal/hepatic function.\n\n \n\nContraindications\nGLIMITERIS MV1 0.2 is not suitable for patients with:\n\nType 1 diabetes or diabetic ketoacidosis.\n\nSevere renal impairment (eGFR <30 mL/min/1.73 m²).\n\nHepatic dysfunction.\n\nSevere gastrointestinal diseases.\n\nHistory of lactic acidosis.\n\nHypersensitivity to Glimepiride, Voglibose, or Metformin.\n\nPregnancy and lactation (unless strictly advised by a physician).\n\n \n\nWarnings and Precautions\nHypoglycemia: Risk is higher when combined with other antidiabetics or with missed meals.\n\nLactic Acidosis: A rare but life-threatening effect of Metformin—renal function monitoring is essential.\n\nGI Side Effects: Voglibose and Metformin may cause bloating, flatulence, or diarrhea (usually temporary).\n\nVitamin B12 Monitoring: Long-term Metformin use may reduce B12 absorption.\n\nLiver and Kidney Function: Regular monitoring is recommended for safe long-term use.\n\n \n\nAdverse Effects\nCommon:\nGlimepiride: Mild hypoglycemia, dizziness, slight weight gain.\n\nVoglibose: Gas, abdominal discomfort, mild diarrhea.\n\nMetformin SR: Nausea, bloating, metallic taste, loose stools.\n\nRare but Serious:\nLactic acidosis (from Metformin).\n\nSevere hypoglycemia (especially if meals are skipped).\n\nAllergic reactions such as rash, itching, or swelling.\n\nElevated liver enzymes.\n\nSeek medical attention if symptoms such as rapid breathing, confusion, severe fatigue, or muscle pain occur.\n\n \n\nDrug Interactions\nIncreased hypoglycemia risk: With insulin, beta-blockers, and sulfonylureas.\n\nReduced Metformin efficacy: With corticosteroids, estrogens, and diuretics.\n\nLactic acidosis risk: Higher with alcohol or iodinated contrast agents. ",
"price": 263.0,
"discountamount": 80.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2182,
"imageuri": "https://productimages.withfloats.com/actual/69abe998ad5b8f3f9ba863c2.png",
"tileimageuri": "https://productimages.withfloats.com/tile/69abe998ad5b8f3f9ba863c2.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-09-25T10:46:50.098Z",
"updatedon": "2026-03-13T10:35:41.824Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//glimepiride-voglibose-metformin/2182",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIMITERIS MV1 0.2",
"category": "DIABETIC RANGE",
"tags": [
"glimepiride voglibose metformin tablets",
"glimepiride voglibose metformin combination",
"glimepiride voglibose metformin dosage",
"glimepiride voglibose metformin uses",
"glimepiride voglibose metformin composition",
"glimepiride voglibose metformin tablets ip",
"glimepiride voglibose metformin triple combination",
"glimepiride voglibose metformin for type 2 diabetes",
"triple drug combination for type 2 diabetes",
"diabetes medicine for high fasting and pp sugar",
"medicine for uncontrolled diabetes type 2",
"combination tablets for diabetes management",
"combination tablets for diabetes management",
"when to take glimepiride voglibose metformin tablets",
"who should take glimepiride voglibose metformin",
"benefits of glimepiride voglibose metformin tablets",
"side effects of glimepiride voglibose metformin"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "6ae2fef4545d3197abde920c",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Faropenem Disperible Tablets 100 mg",
"description": "Faropinom 100 DT is a prescription-only antibiotic that provides 100 mg of Faropenem in a dispersible tablet. Faropenem is a penem-type beta-lactam, and doctors use it to treat bacterial infections only when the causative organism is likely to respond to it.\n\nAbout Faropinom 100 DT\n\nThe active ingredient, Faropenem, stops bacteria from building a proper cell wall. The weakened bacteria cannot survive, which helps the body clear a susceptible infection.\n\nThe tablet is meant to be mixed into water before it is taken. This can suit patients who find whole tablets hard to swallow. It should be used strictly as prescribed and according to the leaflet in the pack.\n\nProduct Snapshot\nFeature\tDetails\nBrand\tFaropinom 100 DT\nActive ingredient\tFaropenem 100 mg\nClass\tPenem beta-lactam antibiotic\nForm\tDispersible tablet\nMode of action\tBlocks bacterial cell-wall synthesis\nAvailability\tPrescription-only; subject to Indian regulations\nPurpose\tTreating susceptible bacterial infections on a doctor’s advice\nWhere Faropenem May Be Used\n\nWhether Faropenem is chosen depends on the patient’s condition, the bacteria involved (suspected or confirmed), prevailing treatment guidelines and the approved product information. Infections for which it may be considered include:\n\nRespiratory infections: bacterial infections of the airways or lungs, where the organism is sensitive to Faropenem.\nUrinary infections: bacterial infections of the bladder or wider urinary tract, at a clinician’s discretion.\nEar, nose and throat infections: certain bacterial infections of the ears, throat or sinuses, after examination.\nSkin and soft-tissue infections: selected bacterial skin infections, depending on severity and the organisms responsible.\nOther infections: any further use must follow approved indications, laboratory susceptibility and the treating doctor’s judgement.\n\nPlease note: This antibiotic does not suit every infection. It should never be assumed appropriate for all chest, urinary, skin or genital conditions. Only a qualified healthcare professional can decide whether it is right for a particular patient.\n\nNotable Characteristics\n\n1. Bactericidal action. Faropenem attacks susceptible bacteria by interfering with the machinery that builds their cell walls. How well it works depends on the species and its susceptibility.\n\n2. Activity against some enzyme-producing bacteria. Certain bacteria make beta-lactamase enzymes that disable some beta-lactam antibiotics. Faropenem can work against some of these organisms, but results differ by bacterium and resistance mechanism. It is not a universal answer to resistant infections.\n\n3. Easy-to-prepare format. The tablet is dispersed in water following the pack instructions, which helps those who struggle with swallowing conventional tablets.\n\n4. Focused treatment. Matched to the right infection, it targets the responsible bacteria. Choosing the right antibiotic improves outcomes and limits needless antibiotic exposure.\n\n5. Oral route. When oral therapy is clinically suitable, treatment can proceed without injections. The prescriber decides the route based on the patient’s condition.\n\nHow Faropenem Works\n\nFaropenem attaches to penicillin-binding proteins, which bacteria rely on to assemble and maintain their cell walls. With these proteins blocked, the wall cannot form properly, the bacterial structure weakens and the cell dies. This makes Faropenem bactericidal against susceptible organisms. It does not act on viruses and cannot treat every bacterial infection.\n\nDosing and Administration\n\nThe dose is set by the doctor after considering age, body weight (where relevant), the type and seriousness of the infection, and kidney function.\n\nDose: use only the strength and quantity prescribed.\nFrequency: follow the daily schedule given to you; do not alter it yourself.\nDuration: finish the prescribed course without lengthening or shortening it unless your doctor says so.\nPreparation: disperse the tablet as directed in the leaflet or by your pharmacist.\nMissed dose: check the leaflet or ask a pharmacist. Never double up to make up for a forgotten dose.\n\nNo single dosing plan fits all patients, so a general range should never replace a personal prescription.\n\nPossible Side Effects\n\nAs with other antibiotics, reactions can occur, and they vary from person to person.\n\nMilder effects may include:\n\nNausea or stomach upset\nAbdominal discomfort\nLoose stools or diarrhoea\nRash or itching\nHeadache or dizziness\n\nSpeak to a healthcare professional if these continue, become bothersome or get worse.\n\nGet medical help promptly for:\n\nSerious allergy: swelling of the face, lips, tongue or throat, or trouble breathing is an emergency.\nSevere diarrhoea: persistent, watery or bloody stools may signal a serious antibiotic-related complication.\nSevere skin reaction: widespread rash, blisters or peeling skin needs urgent assessment.\nLiver concerns: yellow skin or eyes, or dark urine, should be checked quickly.\n\nThis list is not exhaustive. Refer to the product information and your doctor for advice specific to you.\n\nPrecautions and Warnings\nAllergies: tell your doctor about any past allergy to Faropenem, penicillins, cephalosporins or other beta-lactams.\nKidney health: report any kidney disease or reduced function, as it can affect suitability and dosing.\nPregnancy and breastfeeding: consult your doctor first if you are pregnant, planning pregnancy or nursing. Use only after a personal benefit–risk assessment.\nOther medicines: share a full list of prescription drugs, over-the-counter products and supplements so interactions can be checked.\nAntibiotic resistance: take Faropenem only for a suitable bacterial infection. Misuse and incorrect dosing fuel resistance.\nMedical history: discuss existing conditions and earlier drug reactions before starting.\nWho Is It For?\n\nFaropinom 100 DT may be considered for patients who need an antibiotic for a susceptible bacterial infection and for whom this dispersible form is suitable. The prescriber decides based on examination, the likely or confirmed organism, individual risk factors and current guidance. It should not be self-started for fever, cough or sore throat without first establishing that an antibiotic is needed.\n\nBuying Faropinom 100 DT in India\n\nBefore purchasing, confirm the brand, strength, manufacturer and the legitimacy of the seller. For safety:\n\nGet a prescription from a registered medical practitioner.\nBuy from a licensed pharmacy or a duly authorised online pharmacy.\nInspect the name, strength, batch number, expiry date and pack condition.\nStore it as the packaging directs.\nAsk the pharmacist if anything is unclear.\n\nPrice and availability: these differ by manufacturer, pack size, pharmacy and location. Confirm current details with a licensed seller rather than an unverified figure.\n\nFrequently Asked Questions\n\n1. What is Faropinom 100 DT prescribed for?\nIt contains Faropenem 100 mg and is used for certain bacterial infections when the organism is susceptible and the medicine is clinically suitable.\n\n2. Is it an antibiotic?\nYes. Faropenem is a penem-class beta-lactam that disrupts bacterial cell-wall formation.\n\n3. What is the active ingredient?\nFaropenem 100 mg. Check the pack for full composition details.\n\n4. Will it cure a common cold?\nNo. Colds are viral, and antibiotics do not act on viruses.\n\n5. How do I take it?\nExactly as prescribed. Prepare the dispersible tablet in water as described in the leaflet or by your pharmacist.\n\n6. What is the right dose?\nIt depends on the infection, your age, kidney function and other individual factors. Follow your doctor’s prescription.\n\n7. How long is the course?\nThe duration depends on the infection and your response. Complete the course unless your doctor changes it.\n\n8. What side effects can occur?\nStomach upset, nausea, diarrhoea, headache and skin reactions are possible. Seek advice if they persist or become severe.\n\n9. Can it cause diarrhoea?\nYes, as antibiotics can. Contact a healthcare professional quickly if it is severe, long-lasting or bloody.\n\n10. Can I stop once I feel better?\nDo not stop or alter treatment on your own. Talk to your doctor about side effects or if you think treatment is no longer needed.\n\n11. Is it safe in pregnancy?\nA doctor must assess this individually. Do not use it in pregnancy without medical advice.\n\n12. Can I use it while breastfeeding?\nAsk your doctor first. The decision rests on available safety data and your circumstances.\n\n13. Can people with kidney problems take it?\nThey should tell their doctor beforehand, who will decide on suitability and any adjustment.\n\n14. Is Faropenem a penicillin?\nNo, it is a penem. Both are beta-lactams, so discuss any antibiotic allergy history with your prescriber.\n\n15. Is alcohol allowed during treatment?\nAsk your doctor or pharmacist, especially if you have other conditions or take other medicines. Avoid alcohol if it worsens symptoms.\n\n16. What if I miss a dose?\nConsult the leaflet or your pharmacist. Do not take a double dose unless a professional tells you to.\n\n17. Does it work on resistant bacteria?\nIt may act on certain bacteria that resist some other antibiotics, but this depends on the organism and resistance mechanism. Medical assessment is essential.\n\n18. Can it be used for any infection?\nNo. It is for suitable bacterial infections only, chosen through clinical assessment and, where needed, lab testing.\n\n19. What does it cost in India?\nConfirm the current price with a licensed pharmacy, as it varies by pack size, maker and location.\n\n20. Where can I buy it?\nEnquire at a licensed local or authorised online pharmacy. A valid prescription may be required under applicable rules.\n\nConclusion\n\nFaropinom 100 DT is a dispersible Faropenem 100 mg antibiotic for selected bacterial infections, to be used under a qualified healthcare professional’s guidance. It works by disrupting bacterial cell-wall formation, and the dispersible form offers an alternative for patients who find standard tablets difficult.\n\nResponsible use depends on accurate diagnosis, the right antibiotic choice, sticking to the prescribed regimen and watching for side effects. Always consult a healthcare professional before starting, stopping or changing antibiotic treatment.",
"price": 590.0,
"discountamount": 177.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2506,
"imageuri": "https://productimages.withfloats.com/actual/6ae2fef754689b1ff0217bf5.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6ae2fef754689b1ff0217bf5.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-10-29T08:08:20.798Z",
"updatedon": "2026-10-29T08:08:20.798Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//faropenem-disperible-tablets-100-mg/2506",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "Faropinom 100 DT",
"category": null,
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a68501b7848bdec5254a606",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Potassium Iodide,Calcium Chloride & Sodium Chloride Eye Drops",
"description": "Potassium Iodide, Calcium Chloride & Sodium Chloride Eye Drops are specially formulated ophthalmic drops used to support eye health and help manage certain corneal conditions under medical supervision. This unique combination works by improving the natural healing process of the cornea while helping reduce corneal opacity and assisting in the absorption of abnormal calcium deposits in selected eye disorders. Ophthalmologists may prescribe these eye drops for patients experiencing corneal degeneration, corneal scars, or other conditions affecting the transparency of the cornea.\n\nIf you are looking for an effective eye care solution recommended by eye specialists, Potassium Iodide, Calcium Chloride & Sodium Chloride Eye Drops offer a clinically trusted option. Before purchasing, it is essential to understand their uses, benefits, dosage, precautions, and possible side effects to ensure safe and effective treatment.\n\nWhat are Potassium Iodide, Calcium Chloride & Sodium Chloride Eye Drops?\n\nPotassium Iodide, Calcium Chloride & Sodium Chloride Eye Drops are prescription ophthalmic drops formulated to improve corneal health and support recovery from specific eye conditions involving corneal opacity or calcium deposition.\n\nEach ingredient plays an important role:\n\nPotassium Iodide helps promote the absorption of abnormal corneal deposits and supports corneal healing.\nCalcium Chloride maintains electrolyte balance necessary for healthy eye tissues.\nSodium Chloride helps maintain proper osmotic pressure and provides hydration to the ocular surface.\n\nTogether, these ingredients help preserve corneal clarity, improve comfort, and support better visual function when used as directed by an ophthalmologist.\n\nUses of Potassium Iodide, Calcium Chloride & Sodium Chloride Eye Drops\n\nDoctors may prescribe these eye drops for several ophthalmic conditions, including:\n\nTreatment of corneal opacity\nManagement of superficial corneal scars\nCorneal degeneration\nSupportive treatment in corneal calcium deposits\nPost-corneal injury recovery\nCertain chronic corneal disorders\nImproving corneal transparency\nSupporting healing after eye surgery (when advised)\nAdjunct therapy in selected ophthalmic conditions\n\nThese eye drops should always be used according to an eye specialist's recommendation.\n\nBenefits of Potassium Iodide, Calcium Chloride & Sodium Chloride Eye Drops\n\nUsing these eye drops as prescribed offers several advantages:\n\nHelps reduce corneal opacity\nSupports natural corneal healing\nAssists in dissolving abnormal calcium deposits\nMaintains healthy electrolyte balance in eye tissues\nHelps preserve corneal transparency\nImproves ocular lubrication\nReduces eye discomfort associated with corneal disorders\nSupports better visual clarity\nSuitable for long-term ophthalmic management when recommended\nEasy-to-use sterile eye drop formulation\nHow Do Potassium Iodide, Calcium Chloride & Sodium Chloride Eye Drops Work?\n\nThe effectiveness of this ophthalmic formulation comes from the combined action of its active ingredients.\n\nPotassium Iodide is believed to facilitate the gradual absorption of certain corneal deposits and support tissue repair. It has traditionally been used in ophthalmology to manage corneal opacities and related disorders.\n\nCalcium Chloride contributes to maintaining normal cellular function and electrolyte balance within ocular tissues, supporting healthy corneal physiology.\n\nSodium Chloride helps regulate osmotic balance, reduces excess fluid accumulation, and keeps the eye surface adequately hydrated.\n\nTogether, these ingredients help restore a healthier corneal environment and improve overall eye comfort.\n\nHow to Use Potassium Iodide, Calcium Chloride & Sodium Chloride Eye Drops\n\nFor the best results:\n\nWash your hands thoroughly.\nShake the bottle if instructed.\nTilt your head backward.\nPull the lower eyelid downward.\nInstill the prescribed number of drops.\nClose your eyes gently for 1–2 minutes.\nAvoid touching the dropper tip.\nReplace the cap tightly after each use.\n\nAlways follow your ophthalmologist's dosage instructions.\n\nRecommended Dosage\n\nThe dosage depends on:\n\nAge\nEye condition\nSeverity of disease\nMedical history\nResponse to treatment\n\nMost patients are advised to use the drops 2–4 times daily, but only your ophthalmologist can determine the correct dosage.\n\nDo not increase or decrease the frequency without medical advice.\n\nPossible Side Effects\n\nLike all medications, these eye drops may cause mild side effects.\n\nCommon side effects include:\n\nMild burning sensation\nTemporary eye irritation\nWatery eyes\nRedness\nMild itching\nTemporary blurred vision after instillation\n\nRare side effects include:\n\nAllergic reaction\nPersistent eye pain\nSevere redness\nSwelling around the eyes\nVision changes\n\nSeek immediate medical attention if severe symptoms occur.\n\nPrecautions Before Using These Eye Drops\n\nBefore using Potassium Iodide, Calcium Chloride & Sodium Chloride Eye Drops, inform your doctor if you have:\n\nAllergy to iodine or any ingredient\nThyroid disorders\nRecent eye surgery\nEye infection\nContact lens use\nPregnancy\nBreastfeeding\nOther ongoing eye medications\n\nAvoid sharing your eye drops with others.\n\nDrug Interactions\n\nInform your doctor if you are using:\n\nOther prescription eye drops\nAntibiotic eye medications\nSteroid eye drops\nLubricating eye drops\nAnti-glaucoma medications\nEye ointments\n\nMaintain a gap of at least 10–15 minutes between different eye medications unless instructed otherwise.\n\nWho Should Buy Potassium Iodide, Calcium Chloride & Sodium Chloride Eye Drops?\n\nThese eye drops may be suitable for:\n\nPatients with corneal opacity\nIndividuals recovering from corneal injury\nPeople with chronic corneal degeneration\nPatients requiring supportive corneal therapy\nIndividuals advised by ophthalmologists for corneal calcium deposits\n\nThey are not meant for self-medication and should only be purchased after medical consultation.\n\nStorage Instructions\n\nStore the bottle:\n\nBelow 25°C\nAway from sunlight\nKeep tightly closed\nDo not freeze\nKeep away from children\nDiscard within the recommended period after opening, as advised on the label\nWhy Choose Potassium Iodide, Calcium Chloride & Sodium Chloride Eye Drops?\n\nPatients and healthcare professionals prefer this ophthalmic formulation because it:\n\nSupports corneal recovery\nHelps maintain eye tissue health\nOffers a balanced electrolyte formulation\nIs easy to administer\nComes in a sterile ophthalmic solution\nIs prescribed by ophthalmologists for selected corneal disorders\nSupports long-term eye care under medical supervision\nBuying Guide\n\nWhen purchasing Potassium Iodide, Calcium Chloride & Sodium Chloride Eye Drops, make sure you:\n\nBuy from a trusted pharmacy or authorized online medical store.\nVerify the manufacturing and expiry dates.\nEnsure the bottle is properly sealed.\nUse only on the advice of an ophthalmologist.\nRead the patient information leaflet before use.\nStore the bottle correctly after opening.\nFrequently Asked Questions (FAQs)\n1. What are Potassium Iodide, Calcium Chloride & Sodium Chloride Eye Drops used for?\n\nThese eye drops are mainly prescribed to support the treatment of corneal opacity, corneal degeneration, and certain corneal calcium deposits under an ophthalmologist's supervision.\n\n2. Can these eye drops improve vision?\n\nThey do not directly improve eyesight but may help improve corneal clarity in suitable patients, which can contribute to better vision depending on the underlying condition.\n\n3. Are these eye drops safe for long-term use?\n\nThey may be used for extended periods only if recommended and regularly monitored by your eye specialist.\n\n4. Can I wear contact lenses while using these eye drops?\n\nIt is generally advisable to remove contact lenses before application and reinsert them only after the time recommended by your doctor or the product instructions.\n\n5. How many times should I use these eye drops daily?\n\nUse them exactly as prescribed by your ophthalmologist. Do not change the dosing schedule without medical advice.\n\n6. Can children use Potassium Iodide, Calcium Chloride & Sodium Chloride Eye Drops?\n\nChildren should use these eye drops only when prescribed by a qualified ophthalmologist.\n\n7. What should I do if I miss a dose?\n\nApply the missed dose as soon as you remember unless it is almost time for your next scheduled dose. Do not use extra drops to make up for a missed dose.\n\n8. Can these eye drops cause blurred vision?\n\nTemporary blurred vision may occur immediately after instillation. Avoid driving or operating machinery until your vision becomes clear.\n\n9. Are these eye drops available without a prescription?\n\nAvailability depends on local regulations, but they should only be used under medical supervision due to their specialized ophthalmic indications.\n\n10. Can these eye drops be used with other eye medications?\n\nYes, but keep a gap of at least 10–15 minutes between different eye medications unless your ophthalmologist advises otherwise.\n\n11. How long does one bottle last?\n\nThe duration depends on the prescribed dosage. Always discard the bottle according to the manufacturer's instructions after opening.\n\n12. Who should avoid using these eye drops?\n\nPeople with known allergies to iodine or any ingredient, untreated eye infections, or specific medical conditions should consult their doctor before use.\n\nConclusion\n\nPotassium Iodide, Calcium Chloride & Sodium Chloride Eye Drops are a specialized ophthalmic formulation designed to support corneal health, reduce corneal opacity, and assist in the management of selected corneal disorders. When used under the guidance of an ophthalmologist, these eye drops can contribute to healthier corneal tissue, improved ocular comfort, and better visual outcomes. Always follow the prescribed dosage, maintain proper eye hygiene, and attend regular follow-up appointments to achieve the best treatment results. This balanced formulation remains a trusted option for patients seeking effective support for corneal care and long-term eye health.",
"price": 105.0,
"discountamount": 32.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2483,
"imageuri": "https://productimages.withfloats.com/actual/6a68501e9f60f1b86cca589e.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a68501e9f60f1b86cca589e.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-07-28T06:45:47.031Z",
"updatedon": "2026-07-28T06:45:47.031Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//potassium-iodide-calcium-chloride-sodium-chloride-eye-drops/2483",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "CIPVISION SODICLOR 3D",
"category": "Opthalmology Range",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a5f6b161d694a536c1e0e96",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Minoxidil Gel 5% w/w",
"description": "Losing hair gradually is something almost everyone worries about at some point — and the reasons behind it are rarely simple. Genetics, hormonal shifts, chronic stress, poor nutrition, and even environmental exposure can all play a part in thinning hair over time. MINOXIHAIR GEL 5%, formulated with Minoxidil Gel 5% w/w, is a topical treatment designed to work directly at the source of the problem — the hair follicle itself — helping to slow further loss and support new growth with regular, medically guided use.\n\nProduced under strict pharmaceutical manufacturing standards, MINOXIHAIR GEL 5% is built as a lightweight, easy-to-apply gel that absorbs efficiently into the scalp, delivering its active ingredient exactly where it's needed. It is generally intended for adults dealing with androgenetic alopecia (the hereditary pattern of hair thinning), and like any active treatment, it should be used under a healthcare professional's guidance.\n\nWhat Exactly Is MINOXIHAIR GEL 5%?\n\nAt its core, MINOXIHAIR GEL 5% is a topical delivery system for Minoxidil — a compound with a long, well-documented history in hair-loss management. Rather than working through the bloodstream like an oral tablet, minoxidil applied this way acts locally: it improves circulation around hair follicles, helping keep the growth phase of the hair cycle active for longer and coaxing follicles that had gone quiet back into activity.\n\nBecause it's applied straight to the scalp rather than swallowed, many people find a topical option like this more appealing — it targets the problem area precisely, without the broader systemic exposure of an oral medicine.\n\nComposition\n\nEach gram of the gel delivers:\n\nMinoxidil 5% w/w\n\nThe exact amount used and how long treatment should continue is something a dermatologist or physician should determine based on the individual's specific hair-loss pattern.\n\nThe Science Behind How Minoxidil Works\n\nResearchers don't have a complete, settled explanation for every mechanism behind minoxidil's effect on hair, but decades of clinical use have pointed to several likely actions:\n\nImproves local blood flow around the hair follicles\nReactivates follicles that have become dormant\nLengthens the anagen (active growth) phase of each hair strand\nShortens the telogen (resting) phase that precedes shedding\nEncourages the growth of thicker, sturdier hair strands\nSlows the progression of ongoing thinning\nSupports a scalp environment more conducive to healthy hair growth\n\nWith regular use over several months, many people first notice less hair falling out, followed later by a gradual improvement in overall thickness and coverage.\n\nWhat Is MINOXIHAIR GEL 5% Used For?\n\nThis gel is generally recommended for a range of hair-thinning situations, including:\n\nMale pattern baldness (androgenetic alopecia)\nFemale-pattern thinning, when a physician determines it's appropriate\nThinning concentrated around the crown\nA receding hairline in candidates who are likely to respond\nHereditary hair loss caught in its early stages\nSupporting regrowth once thinning has already begun\nPreserving the hair density a person currently has\nGeneral improvement in scalp coverage\n\nHow well it works for any individual depends heavily on how long the hair loss has been going on, how the person's body responds to treatment, and — critically — how consistently the gel is applied.\n\nKey Benefits of Using MINOXIHAIR GEL 5%\n\nWhen used consistently and under professional supervision, this treatment may offer:\n\nEncourages New Hair Growth Helps “wake up” follicles that have stopped producing visible hair.\n\nCuts Down on Excess Shedding Reduces the abnormal hair fall that comes with androgenetic alopecia.\n\nBuilds Greater Hair Density Supports fuller, thicker-looking hair as treatment continues.\n\nSupports Healthier Follicles Improves the flow of oxygen and nutrients to the scalp's hair-producing structures.\n\nConvenient Gel Format Spreads smoothly and evenly, making daily use straightforward.\n\nFits Into a Long-Term Routine Designed to be part of an ongoing hair-management plan, guided by a professional.\n\nWho Might Benefit From This Treatment?\n\nMINOXIHAIR GEL 5% is typically considered for adults facing:\n\nHair loss with a genetic/hereditary basis\nHair thinning that's steadily progressing\nEarly indications of balding\nNoticeable thinning at the crown\nDiffuse thinning spread across the scalp\nHair loss specifically tied to androgenetic alopecia\n\nIt's worth stressing: a dermatologist visit before starting is the right first step, since not everyone's hair loss pattern will respond the same way to minoxidil.\n\nHow to Apply MINOXIHAIR GEL 5% Correctly\n\nGetting the technique right matters as much as the product itself:\n\nStart with a clean, fully dry scalp.\nApply only the amount your doctor has recommended to the affected area.\nSpread it gently using clean fingertips.\nWash your hands thoroughly right after applying.\nLet the gel air-dry naturally — don't rush this step.\nHold off on washing your scalp immediately afterward.\nStick to the schedule your doctor has laid out.\n\nUsing more than the recommended amount won't speed up or improve results — it simply increases the chance of irritation.\n\nWhat Kind of Timeline Should You Expect?\n\nHair regrowth with minoxidil is a slow, gradual process — patience is genuinely part of the treatment:\n\nWeeks 2–8: Some people notice shedding starting to slow down.\nMonths 3–4: Early, subtle signs of new growth may begin appearing.\nMonths 4–6: Hair often looks and feels noticeably thicker.\nMonths 6–12: The most visible cosmetic improvement typically shows up here, provided use has been consistent.\n\nEveryone's timeline looks a little different, but one thing stays constant across almost all users: skipping applications or stopping early tends to undo progress.\n\nPossible Side Effects\n\nAs with any active treatment, some people experience side effects.\n\nMore commonly seen:\n\nMild irritation of the scalp\nItchiness\nDryness\nRedness\nA brief uptick in shedding during the first few weeks (often mistaken for the treatment failing, when it's actually a normal transitional phase)\nA burning feeling where it's applied\n\nLess commonly seen:\n\nGrowth of unwanted hair on the face\nLightheadedness\nSwelling\nA noticeably faster heartbeat\nAllergic-type reactions\n\nAnyone experiencing a severe reaction should seek medical care right away rather than waiting it out.\n\nPrecautions to Keep in Mind\n\nTalk to your healthcare provider before starting if you:\n\nCurrently have a scalp infection or another skin condition\nHave a history of heart disease or low blood pressure\nAre pregnant or breastfeeding\nAre already using another topical product on your scalp\nHave a known sensitivity or allergy to minoxidil or any ingredient in the formulation\n\nKeep the gel away from your eyes, mouth, and any broken or irritated skin.\n\nStorage Instructions\nStore at temperatures below 25°C\nKeep it out of direct sunlight\nMake sure the container stays tightly sealed\nNever freeze it\nStore well out of children's reach\nWhy Consider MINOXIHAIR GEL 5%?\n\nMINOXIHAIR GEL 5% is built to deliver a dependable, pharmaceutical-grade form of topical minoxidil therapy. Manufacturing follows rigorous quality checks to keep the formulation consistent from batch to batch, so users can rely on the same performance every time. The gel base itself makes daily application simple, while still delivering the active ingredient exactly where it needs to go.\n\nPaired with good overall habits — balanced nutrition, manageable stress levels, and regular check-ins with your doctor — MINOXIHAIR GEL 5% can be a meaningful part of a long-term approach to keeping hair fuller and healthier.\n\nPrice | Use under medical guidance – consult your dermatologist.\n\nFrequently Asked Questions\n\n1. Is MINOXIHAIR GEL 5% used for hair regrowth? Yes. It's intended for androgenetic alopecia and works to stimulate regrowth when applied consistently under a doctor's supervision.\n\n2. How long before I notice a difference? Most people start seeing visible change somewhere between the 3- and 6-month mark, though this varies from person to person.\n\n3. Can women use this product? In some cases, yes — but only under the direction of a qualified healthcare provider who can confirm it's the right fit.\n\n4. Do I need to keep using it once my hair grows back? Generally, yes. Results from minoxidil tend to fade gradually if treatment stops, so continued use is usually necessary to maintain them — always follow your doctor's specific advice.\n\n5. Is it okay to use hair oil alongside this gel? Check with your dermatologist first, since other scalp products can interfere with how well the gel absorbs.\n\n6. Will this permanently cure baldness? No — it manages hereditary hair loss and supports regrowth, but it isn't a one-time cure. Ongoing use is typically what maintains the results.\n\n7. What happens during the first few weeks of use? Some people notice a temporary increase in shedding early on — this is usually a normal part of the hair cycle resetting, not a sign the treatment isn't working.\n\n8. Can I apply more than the recommended amount to speed up results? No — applying extra doesn't accelerate growth and mainly raises the risk of scalp irritation.\n\n9. Is a prescription needed for this gel? Since it contains an active pharmaceutical ingredient, it should be used under a dermatologist's or doctor's guidance rather than self-prescribed.\n\n10. What should I avoid while using this treatment? Avoid getting the gel in your eyes, mouth, or on broken skin, and avoid combining it with other scalp treatments without checking with your doctor first.",
"price": 720.0,
"discountamount": 216.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2481,
"imageuri": "https://productimages.withfloats.com/actual/6a5f6b185c5af5a73198ab22.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a5f6b185c5af5a73198ab22.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-07-21T12:50:30.696Z",
"updatedon": "2026-07-21T12:50:30.696Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//minoxidil-gel-5-w-w/2481",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "MINOXIHAIR GEL 5%",
"category": "DERMATALOGY",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
}
],
"hasmoreitems": false,
"isapirequest": false,
"totalresults": 27,
"query": null,
"floatingpoint": null
}